Finally, the clinical relevance of these findings is enhanced by increased PANX1 expression observed in AAA patients, as well as a correlative retrospective study showing a significant association with overall decreased mortality in AA patients with Panx1 inhibitors. The gene discussed is PANX1; the disease is triple-A syndrome.